Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Norton Rose Fulbright Canada LLP
Health Canada is proposing to change the way that it regulates non-prescription drugs, natural health products and cosmetics in Canada, which will now be referred to collectively as "self-care products."
Norton Rose Fulbright Canada LLP
The Ontario Ministry of Health and Long-Term Care recently updated the Ontario Guidelines for Drug Submission and Evaluation ("Guidelines").
Blake, Cassels & Graydon LLP
The Healthy Menu Choices Act will require food service chains with 20 or more locations in Ontario to disclose calorie information for most standard food and drink items on menus, labels, tags and signage.
McMillan LLP
This approach would still include actions such as facility inspection, complaint response, and product testing.
Norton Rose Fulbright Canada LLP
Teva also asserted that the Trial Judge erred by applying the doctrine of claim differentiation to construe the promise and by relying on the patent's abstract in construing the promise.
Torys LLP
The Government of Canada published a Consultation Paper proposing regulatory changes to a class of products identified as "self-care products," namely cosmetics, natural health products and non-prescription drugs.
Borden Ladner Gervais LLP
The Fact Sheet sets out a number of requirements that the IPC will expect health information custodians to meet if they decide to use email to communicate personal health information.
Norton Rose Fulbright Canada LLP
The court also found that all of the alleged generic products infringed the asserted claims of the '426 Patent. Quantification will be determined in a subsequent proceeding.
Miller Thomson LLP
Under the Corporations Information Act (Ontario) (the "Act"), corporations are required to file an Annual Return with the Ministry of Government and Consumer Services (the "Ministry") within six months of the corporation's financial year end to update the public record.
Norton Rose Fulbright Canada LLP
The Fonds de recherche du Québec – Santé (Quebec health research fund) and the Quebec Minister of Health and Social Services recently published new standard legal clauses...
Norton Rose Fulbright Canada LLP
The role and powers of the Patented Medicine Prices Review Board (the "PMPRB" or the "Board") are at issue in a number of recent proceedings.
Borden Ladner Gervais LLP
​The Provincial government intends to propose legislation that would uphold and reinforce a zero tolerance policy on the sexual abuse of patients by regulated health professionals.
Norton Rose Fulbright Canada LLP
On September 6 the Supreme Court of British Columbia began to hear a case that could fundamentally change the landscape of Canadian healthcare.
Miller Thomson LLP
Health care professionals are prohibited from engaging in sexual acts, conduct, or behaviour with their patients. It is professional misconduct to engage in such conduct, which is defined as "sexual abuse"...
Bennett Jones LLP
On August 24, 2016, Health Canada implemented the Access to Cannabis for Medical Purposes Regulations (ACMPR), replacing the Marihuana for Medical Purposes Regulations (MMPR).
Gowling WLG
While the medical community recognizes that the emergence and spread of antimicrobial resistance (AMR) in humans is a potential disaster for humanity, and that it is the overuse of antimicrobials in human medicine that is the largest contributor, there is still a broad consensus that the use of antibiotics in animals may contribute to the problem, though the degree is still unclear.
Gowling WLG
3D printing is the new buzz technology being used to replicate human tissues, fighter jet parts, and human prosthetics.
Gowling WLG
The Government of Ontario has released proposed amendments to clarify the calorie disclosure requirements pursuant to the Healthy Menu Choices Act, 2015.
Borden Ladner Gervais LLP
We are fortunate to be writing this Toolkit at a time when mental illness is receiving much needed attention in Ontario and across Canada.
Norton Rose Fulbright Canada LLP
Hospira Healthcare Corporation, together with Celltrion Healthcare Co., Ltd. and Celltrion, Inc. are involved in a patent infringement/impeachment action concerning an unidentified "proposed product".
Latest Video
Most Popular Recent Articles
Norton Rose Fulbright Canada LLP
The marijuana industry has been high on analysts' lists ever since Justin Trudeau and the Liberal Party were elected in late 2015.
Miller Thomson LLP
The Crop Insurance Act has enabled farmers to obtain production insurance to insure an "agricultural crop or perennial plant" through Agricorp, a Crown agency of the Province of Ontario.
McMillan LLP
While the federal government works towards the eventual legalization of marijuana, including launching a dedicated task force and announcing plans to have a law tabled by spring 2017.
Norton Rose Fulbright Canada LLP
The patent identifies the need to develop polymers that can form thinner films with improved strength and describes that prior efforts to improve polymer material strength often resulted in a reduction in toughness.
Gowling WLG
The Court of Appeal has confirmed that two Genentech patents concerning lyophilised formulations of trastuzumab (the active ingredient in Herceptin) are invalid for obviousness.
Norton Rose Fulbright Canada LLP
The role and powers of the Patented Medicine Prices Review Board (the "PMPRB" or the "Board") are at issue in a number of recent proceedings.
Torys LLP
The new rules allow individuals authorized by their health care practitioner to register with Health Canada to produce a limited amount of cannabis for their own medical purposes.
Torkin Manes LLP
Peter Straszynski explains the workplace challenges of accommodating the legal use of marijuana for medical purposes, and recommends a number of steps...
McCarthy Tétrault LLP
An underlying Health Canada decision was found to have been made for an improper purpose and carried out unfairly.
Torys LLP
A 45-day comment period is currently ongoing in Québec following the publication of draft regulation containing the conditions governing the bidding process for the provision or supply of medications sold in pharmacies.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with